Tag Archives: Type

Can type 1 diabetics take echinacea

The antioxidant properties in Echinacea purpurea are type. I rarely got sick when taking echinecea…but since my Take I no longer take it diabetics willing to chance it until someone proves it otherwise…I mean what can my immune system decide to attack next? Dismiss Notice. Safe for Ear Infections? That causes a general stimulation to… Read More »

FDA Approves Second Biomarker-Based Indication for Merck’s Keytruda (pembrolizumab), Regardless of Tumor Type

Print this page KENILWORTH, N.J.–(BUSINESS WIRE) June 17, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of adult and pediatric patients with unresectable or metastatic tumor mutational burden-high… Read More »

Type 2 diabetes can cause erectile function in men – taking this supplement could help

A new peer-reviewed study, published in the Bratislava Medical Journal, shows that daily supplementation with the natural antioxidant, Pycnogenol can improve the symptoms of erectile dysfunction caused by the condition. This study adds to a body of research showing the benefits of Pycnogenol for improving circulation and blood flow, strengthening the vascular system and managing cholesterol.  Dr… Read More »

11 Diabetes Dos: Your Type 2 Checklist

Anthony Pick, MD, CDCES, an endocrinologist and certified diabetes care and education specialist, Lake Forest, IL. American Diabetes Association, Diabetes Advisor: “Eye Exams for People with Diabetes,” “Standards of Medical Care in Diabetes—2020,” “Preventive Footcare in Diabetes.” American Heart Association: “American Heart Association Recommendations for Physical Activity in Kids and Adults,” “Cardiovascular Disease and Diabetes.”… Read More »

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas Print this page 13 April 2020 — AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo… Read More »

Osia, a New Type of Implantable Hearing Solution by Cochlear, Secures FDA Clearance: Interview

Earlier this month, Cochlear received FDA clearance for the Osia 2 System, the first active osseointegrated steady-state implant (OSI). The Osia System represents a new type of bone conducting hearing solution that uses digital piezoelectric stimulation to transmit sound vibration directly to the inner ear. While present in other auditory equipment and some medical devices,… Read More »